AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Eckert & Ziegler Strahlen- und Medizintechnik AG

Earnings Release Jun 30, 2015

130_rns_2015-06-30_385c8f28-a3a1-46b6-ad6c-4a79692b73ba.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 30 June 2015 16:43

Eckert & Ziegler raises profit expectations

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change in Forecast/Disposal

30.06.2015 16:43

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc press release in accordance with Section 15 WpHG
ISIN DE 0005659700

Eckert & Ziegler raises profit expectations

Berlin, June 30, 2015 - The sale of the shares in Berlin-based OctreoPharm
Sciences GmbH to the French pharmaceuticals company IPSEN took legal effect
today following the receipt of an initial payment. As a result, the
Executive Board of Eckert & Ziegler AG has raised its profit forecast for
2015 to at least EUR 2.00 per share, or just over EUR 10 million. The new
forecast is based on the probability-weighted anticipated income from the
sale of the shares as well as current developments in the first half of the
year.

More detailed information on the effect of the sale of shares on profits as
well as the complete results for the first half of the year will be
released as scheduled on August 4, 2015.

For enquiries, please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.de

30.06.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard), Stuttgart;
Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg,
Munich

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.